Tsurumi, K., Miura, S., Misumi, T., Yoshioka, H., Tokito, T., Sato, Y., Nishino, K., Furuya, N., Kurata, T., Kato, T., Horinouchi, H., Takiguchi, Y., Goto, Y., Tanaka, K., Mori, M., Ikeda, S., Ichihara, E., Tanaka, H., Okamoto, H. (2025). Final overall survival analysis for a phase 3 randomized trial comparing afatinib to chemotherapy in treatment-naïve non-small cell lung cancer with a sensitizing uncommon epidermal growth factor receptor mutation (ACHILLES/TORG1834).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8623